Patent search ap:("THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM") AND inv:"Jingjing Xie" Page 1

1.

发明授权
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer 有权

公开(公告)号：US11377491B2

公开(公告)日：2022-07-05

申请号：US16475223

申请日：2018-01-02

Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

Inventor： X. Charlene Liao , Qiang Liu , Zhiqiang An , Ningyan Zhang , Xun Gui , Chengcheng Zhang , Mi Deng , Jingjing Xie

IPC: C07K16/28 , C12N5/12 , C12N15/85

Abstract: The present disclosure is directed to antibodies binding to LAIR 1 and their treating cancer, inflammation, immune-related diseases or transplantation.

Patent Agency Ranking